Director, Principal Medical Writer, Europe

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As part of our expanding European organization, we are seeking an experienced Principal Regulatory Medical Writer to support the preparation of high-quality regulatory documentation for clinical development and marketing authorization activities across Europe. Working closely with Regulatory Affairs, Clinical Development, Clinical Operations, Biometrics, Pharmacovigilance, CMC, and other cross-functional teams, the successful candidate will author, coordinate and finalize regulatory documents supporting interactions with European and international Health Authorities. The candidate will serve as the lead author for complex regulatory documents and will ensure documents are scientifically accurate, strategically aligned, compliant with ICH, EU and applicable regional requirements, and submission-ready. The successful candidate will play a key role in supporting regulatory interactions with European Health Authorities by developing clear, scientifically robust, and strategically aligned regulatory documentation throughout the product lifecycle. The role will report to the VP, Regulatory Affairs, Europe. Primary Responsibilities: Author, edit and coordinate high-quality clinical regulatory documents, including: Responses to Health Authority questions (EMA, MHRA, Swissmedic, etc). Scientific Advice briefing books and meeting packages. Risk Management Plan (RMP). Periodic safety documents (as applicable). As needed, serve as a medical writing lead for complex clinical regulatory documents, supporting clinical development including protocols, IBs, CSRs, and CTA modules. Other regulatory documents supporting lifecycle management, variations and renewals. Coordinate preparation of responses to regulatory agency requests for information, ensuring consistency across multidisciplinary functional contributions. Lead document planning, review cycles, comment resolution and finalization while ensuring adherence to project timelines. Collaborate closely with Global and European Regulatory Affairs to ensure documents support the overall regulatory strategy. Ensure all documents comply with applicable ICH guidelines, EMA guidance, GCP, company standards and document templates. Facilitate document review meetings and manage cross-functional comment adjudication. Identify potential scientific or regulatory inconsistencies and work with subject matter experts to resolve issues. Maintain consistency across related submission documents and across development programs. Support development and continuous improvement of medical writing processes, templates, style guides and standard operating procedures. Mentor junior writers when appropriate and contribute to departmental best practices. The candidate must have a thorough understanding of oncology drug development, applicable European regulations and guidelines. Required Skills, Experience and Education: Advanced degree (PhD, PharmD, MD, MSc or equivalent) in life sciences or a related scientific discipline. Minimum 10+ years of regulatory medical writing experience within the biotechnology or pharmaceutical industry. Demonstrated experience authoring documents supporting European regulatory submissions. Experience preparing responses to…